XRAY, US24906P1093

Dentsply Sirona stock gets a seventh North American dealer deal

Published on 10/07/2026 at 00:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dentsply Sirona stock was last at USD 8.56 after a 1.27 percent fall on October 5, 2026. Q2 revenue reached USD 898 million, while consensus sets a USD 13.73 target.

XRAY, US24906P1093, Illustration mit AI erstellt.
XRAY, US24906P1093, Illustration mit AI erstellt.

Dentsply Sirona stock (ISIN US24906P1093) was last at USD 8.56 on Nasdaq on October 5, 2026, down 1.27 percent in the session. The dental technology company then announced a seventh North American dealer partnership enhancement for 2026, giving its connected technology portfolio a fresh distribution channel.

Seventh dealer agreement expands reach

According to StockTitan on October 6, 2026, Midwest Dental Equipment & Supply will begin offering Dentsply Sirona technology in the United States on November 1, 2026. The relationship had previously focused on consumables and now adds digital dentistry solutions supported by Midwest Dental's sales, service and technical teams.

The company said the agreement supports broader access to connected technology and follows partnerships involving Benco Dental, Burkhart Dental, Nashville Dental, Atlanta Dental, Medline Sinclair and Patterson Dental. The commercial logic is direct: more local distribution can improve access to equipment while Dentsply Sirona executes its Return-to-Growth plan.

Q2 revenue beats the estimate

Dentsply Sirona's second-quarter 2026 revenue was USD 898 million, compared with a consensus estimate of USD 889.93 million, according to Yahoo Finance in the August 6, 2026 earnings transcript. Revenue still fell 4.1 percent from the prior-year quarter, while adjusted EPS was flat at USD 0.52.

Operating cash flow reached USD 99 million in Q2/2026, versus USD 48 million a year earlier. Management maintained its 2026 outlook for net sales of USD 3.5 billion to USD 3.6 billion and adjusted EPS of USD 1.40 to USD 1.50, while expecting third-quarter revenue and earnings to decline sequentially because of seasonality.

Consensus target remains above the stock

StockAnalysis lists a Hold consensus from 17 analysts as of October 6, 2026, with an average price target of USD 13.73. The target lies 60.40 percent above the USD 8.56 price, creating a quantified gap between the market quotation and analyst expectations rather than a single-house forecast.

Dentsply Sirona's market capitalization was USD 1.7 billion on October 5, 2026, and the stock had fallen 35.10 percent over the preceding 52 weeks. The USD 8.44 to USD 14.76 52-week range places the latest price 1.42 percent above the low, keeping execution and cash generation central to the investment case.

XRAY stock stays near its yearly low

Dentsply Sirona stock was last at USD 8.56 on Nasdaq at 4:00 p.m. ET on October 5, 2026. The combination of a seventh dealer expansion, a Q2 revenue beat and a USD 13.73 consensus target gives investors three measurable markers for the turnaround.

Dentsply Sirona stock facts

  • Company: DENTSPLY SIRONA Inc.
  • ISIN: US24906P1093
  • Ticker: XRAY
  • Trading venue: Nasdaq
  • Price (as of October 5, 2026, 4:00 p.m. ET): USD 8.56
  • Market capitalization: USD 1.7 billion (as of October 5, 2026)
  • 52-week range: USD 8.44-14.76 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

More news and analyses on Dentsply Sirona stock

Disclaimer...

en | US24906P1093 | XRAY | boerse | 70246374 | bgmi